Partner Content Partner Content Agenda Released for 3D Cell Culture 2018 Agenda Released for 3D Cell Culture 2018
Events Partner Content CRISPR & Precision Gene Editing Congress - Berlin 2017 CRISPR & Precision Gene Editing Congress Berlin 2017
News CRISPR Therapeutics plans Nasdaq launch CRISPR Therapeutics, the Swiss genome-editing company, has filed for a $90 million initial public offering.
News China to begin first in-human CRISPR trial next month Phase 1 trial will investigate safety and tolerability in non-small cell lung cancer.
Digital On AI and computational support of biochemistry, with Alan R... Dr Alan Roth, CEO of Oxford Drug Design, discusses the use of AI to accelerate discovery of new treatments.
Sales & Marketing Sponsored The AI imperative: Establishing the standard for modern clin... The findings from the Medidata-commissioned survey confirm that AI implementation in clinical trials has moved firmly beyond theoretical discussion.
